KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

CLAMYCIN 500 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

500 MG

 

GENERIC NAME:

CLARITHROMYCIN

 

MANUFACTURER:

JULPHAR

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Bronchitis, chronic, acute exacerbation

Infection, ear, middle

Infection, lower respiratory tract

Infection, sinus

Infection, skin and skin structure

Infection, upper respiratory tract

Mycobacterium avium complex

Pharyngitis

Pneumonia

Tonsillitis

Ulcer, H. pylori associated

 

SIDE EFFECTS:

Hepatotoxicity

hypersensitivity reaction

pseudomembranous colitis

thrombocytopenia

Abnormal sensation of taste

gastrointestinal disturbances

headache

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Hypersensitivity to clarithromycin, erythromycins, or other macrolides

>> Renal function impairment, severe

 

ADULT DOSE:

Bronchitis, bacterial exacerbations due to Haemophilus influenzae- Oral, 500 mg every twelve hours for seven to fourteen days . Bronchitis, bacterial exacerbations due to other organisms; or Pneumonia, chlamydial, mycoplasmal, or streptococcal; or Skin and soft tissue infections, uncomplicated- Oral, 250 mg every twelve hours for seven to fourteen days . Mycobacterium avium complex disease, disseminated (prophylaxis) - Oral, 500 mg two times a day . Mycobacterium avium complex disease, disseminated (treatment)- Oral, 500 mg two times a day in combination with other antimycobacterial agents; clarithromycin therapy should continue for life if clinical and mycobacterial improvements are observed . Pharyngitis, streptococcal or Tonsillitis- Oral, 250 mg every twelve hours for ten days . Sinusitis, acute maxillary- Oral, 500 mg every twelve hours for fourteen days . Ulcer, duodenal, Helicobacter pylori -associated (treatment adjunct with amoxicillin and lansoprazole) - Oral, 500 mg in combination with amoxicillin 1000 mg and lansoprazole 30 mg every twelve hours for fourteen days . Ulcer, duodenal, H. pylori -associated (treatment adjunct with omeprazole)- Oral, 500 mg three times a day in combination with omeprazole 40 mg once a day for fourteen days, followed by omeprazole alone 20 mg once a day for fourteen days . Ulcer, duodenal, H. pylori -associated (treatment adjunct with ranitidine bismuth citrate) - Oral, 500 mg three times a day in combination with ranitidine bismuth citrate 400 mg two times a day for fourteen days, followed by ranitidine bismuth citrate alone 400 mg two times a day for fourteen days . Note: Combination therapy with clarithromycin and ranitidine bismuth citrate is not recommended for patients with a creatinine clearance of less than 25 mL per minute (0.41 mL per second) . Note: The dose of clarithromycin should be adjusted in patients with severe renal function impairment (creatinine clearance [CrCl] < 30 mL/min [0.5 mL/sec]). The following dosing guidelines are suggested : Dose for CrCl of > 30 mL/min (0.5 mL/sec) Adjusted dose for CrCl of < 30 mL/min (0.5 mL/sec) 500 mg two times a day 500 mg loading dose, then 250 mg two times a day 250 mg two times a day 250 mg once a day Dosage should not be continued beyond fourteen days in patients with severe renal function impairment .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

This product may not be suitable for young children. See Clarithromycin for Oral Suspension .  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT